Why does my body odour smell like feces?

If your body has a faecal odour that persists despite thorough hygiene, there is a biochemical explanation. The molecule most commonly responsible is skatole, also known as 3-methylindole. It is produced when certain bacteria in the large intestine break down the amino acid tryptophan, and it can enter the bloodstream, pass through the liver, and be excreted through sweat and other secretions.

This is a different biochemical pathway from the sour or onion-like armpit odour most people associate with body odour. Those smells originate from bacteria on the skin surface breaking down sweat precursors. Faecal body odour, in many cases, originates from inside the body. Understanding the distinction is the first step toward managing it.

This article explains what skatole is, how it is produced, how it reaches the skin, what conditions can increase its production, and what the scientific evidence says about addressing it. The claims in this article are grounded in peer-reviewed research. Where the science is still emerging, that is stated explicitly.

1. The molecule behind the smell: skatole

Skatole (3-methylindole) is a nitrogen-containing heterocyclic compound formed during bacterial degradation of the amino acid L-tryptophan in the mammalian intestine.^[1] Its name derives from the Greek skatos, meaning dung, and it has been recognised as a principal contributor to the characteristic odour of faeces since the nineteenth century.

Skatole has an exceptionally low odour detection threshold. Even trace airborne concentrations can produce a perceptible faecal note. Unlike indole, a closely related molecule that smells floral at low concentrations and faecal only at higher concentrations, skatole has a faecal odour character at every detectable concentration. This distinction matters: even trace quantities of skatole reaching the skin surface can produce a perceptible faecal note.

Skatole is fat-soluble. When it reaches the skin through the bloodstream, it accumulates in the skin's own oily layer rather than sitting on the surface where water can wash it away. This is why the odour can persist even after thorough showering: the molecule is embedded in the lipid layer of the skin and is released gradually throughout the day. If you experience body odour that survives showering, our article on why you still smell after showering (publishing shortly) explains that mechanism in full.

In plain terms What is skatole, and why does it smell so strongly?

Skatole is a chemical compound produced by bacteria in your gut. It is the main reason faeces have their characteristic smell. The human nose can detect it at extremely low concentrations, so even tiny amounts reaching your skin can produce a noticeable odour. Because skatole dissolves easily into the oily layer of your skin, it can linger even after you shower.

2. How your gut bacteria produce skatole

The production of skatole begins with tryptophan, one of the nine essential amino acids obtained from dietary protein. Approximately 95% of dietary tryptophan is metabolised through the kynurenine pathway, of which the hepatic arm accounts for roughly 90% and extrahepatic tissues the remainder.^[3] The fraction that escapes this degradation and reaches the colon unabsorbed becomes available to gut bacteria.^[1]

Two distinct microbial pathways convert this colonic tryptophan into odorous metabolites. The first is the indole pathway: more than 85 gram-positive and gram-negative bacterial species possess the enzyme tryptophanase, which converts L-tryptophan directly into indole, pyruvate, and ammonia.^[2] Among the most widely studied indole producers in the human gut is Escherichia coli.^[2] The faecal concentration of indole in healthy adults has been measured in a wide range, from 0.30 to 6.64 millimoles.^[2]

The second pathway produces skatole. Tryptophan is first converted to indole-3-acetic acid (IAA) through an indolepyruvate intermediate, and IAA is then decarboxylated to form skatole. Within the human gut, Clostridium and Bacteroides genera are the primary catalysts for this conversion, though they represent less than 0.01% of the total intestinal microbiota.^[2] Clostridium sporogenes has been identified as a skatole producer in animal studies, though much of this evidence comes from ruminant rather than human gut research.^[6]

The concentration of skatole in healthy human faeces has been reported as approximately 5 micrograms per gram in one study^[2] and 10 to 16 micrograms per gram in another.^[6] In individuals with digestive disorders, faecal skatole can increase substantially, reaching 80 to 100 micrograms per gram.^[2] These figures measure skatole production in the gut. Whether increased gut skatole translates proportionally to increased skatole at the skin surface is an area of active research. What the numbers establish is that gut conditions have a measurable effect on how much skatole the body produces, which is the first link in the chain from gut to skin.

In plain terms Where does skatole come from?

When you eat protein, some of it reaches your large intestine without being fully absorbed. Bacteria living there break down this protein, specifically an amino acid called tryptophan. Two groups of bacteria handle this differently: one group produces indole (which smells floral in small amounts), and another group produces skatole (which smells faecal at any concentration). The amount of skatole produced depends on which bacteria are dominant in your gut and how much protein reaches them.

3. How skatole reaches your skin

Once produced in the colon, skatole is absorbed into the bloodstream. As a lipophilic compound, it crosses the intestinal epithelium readily and is transported to the liver, where several cytochrome P450 enzymes, including CYP1A, CYP2A, CYP2E1, and others, metabolise it before it can reach systemic circulation.

In primary human hepatocytes, skatole acts as a partial agonist of the aryl hydrocarbon receptor (AhR), weakly inducing expression of CYP1A1, CYP1A2, and CYP1B1.^[4] The induction is modest compared to strong AhR activators, and skatole's metabolites (particularly indole-3-carbinol) appear to be more potent inducers than skatole itself. Because some of these same CYP enzymes also metabolise skatole, the relationship creates a self-regulating cycle rather than a runaway amplification. The magnitude of CYP induction varies substantially between individuals.^[4]

Because cytochrome P450 enzymes are responsible for skatole metabolism in the liver, variation in their expression or function between individuals may affect how much skatole escapes hepatic processing and enters systemic circulation. This is a reasonable inference from the known biochemistry, though the direct relationship between CYP expression variability and circulating skatole levels has not been quantified in human studies.

Skatole that escapes hepatic clearance enters systemic circulation and can be excreted through urine, breath, and sweat. Because skatole is lipophilic, it accumulates in the oily layers of the skin and is released gradually. Because skatole arrives at the skin through the bloodstream rather than through localised bacterial activity, it can surface anywhere on the body where sebaceous glands and sweat glands are present. This is not an armpit problem. It is a whole-body problem. The chest, back, torso, groin, and limbs are all potential sites of skatole excretion.

An important note on scientific certainty: the gut production of skatole and its hepatic metabolism are well characterised in peer-reviewed literature. The specific quantification of skatole excretion through human sweat glands is an area of active research with limited direct measurement data. The pathway from gut to skin is established in principle and supported by pharmacokinetic modelling, but the precise contribution of sweat-mediated excretion versus other routes is still being characterised. This article presents what the evidence supports and identifies where the frontier lies.

In plain terms How does a molecule from my gut end up on my skin?

After bacteria in your gut produce skatole, it is absorbed into your bloodstream and carried to your liver. Your liver tries to break it down and send the fragments to your kidneys for removal. If the liver cannot fully clear it, whether due to genetics, liver stress, or sheer volume of skatole, the remainder circulates in your blood. Because skatole dissolves easily into oil, it accumulates in the oily layers of your skin and can be released gradually. This is why the odour can persist throughout the day and survive showering. And because the molecule arrives through the blood, not from bacteria on the skin, it can appear anywhere on the body, not just the armpits. The chest, back, and groin are equally affected.

4. Why some people are affected more than others

Three factors determine an individual's susceptibility to faecal body odour from the skatole pathway: how much skatole their gut produces, how efficiently their liver clears it, and what they eat.

Dietary protein and tryptophan load

Dietary tryptophan load directly modulates intestinal indole production. In laboratory models simulating the human gut microbiome, high-protein diets increase microbial production of indole compared to high-fibre diets, while high-fibre diets favour production of beneficial tryptophan catabolites such as indole-3-propionic acid and indole-3-lactic acid.^[7] Foods especially rich in tryptophan include turkey, chicken, cheese, eggs, soybeans, and chocolate. For a broader look at how diet influences body odour across multiple pathways, our article on foods that cause body odour (publishing shortly) covers the full picture. The more unabsorbed tryptophan that reaches the colon, the more substrate is available for skatole-producing bacteria.

Conversely, preclinical research suggests that increasing dietary fibre can redirect tryptophan metabolism. In controlled animal experiments and defined bacterial communities, dietary fibre suppressed indole production and promoted alternative tryptophan metabolites such as serotonin and indole-3-propionic acid.^[9] In separate in vitro experiments using human faecal samples, prebiotic supplementation reduced proteolytic metabolites including indole.^[8] These are preclinical findings. Whether increasing dietary fibre produces the same effect on skatole in living humans has not been tested in controlled clinical trials. The biological rationale is sound, but the clinical evidence does not yet exist.

Hepatic clearance capacity

As described in the previous section, variation in CYP enzyme induction between individuals may affect how efficiently the liver processes skatole.^[4] Beyond genetics, liver health matters. Any condition that impairs hepatic function, including fatty liver disease, chronic alcohol use, or hepatitis, may reduce skatole clearance and increase the amount entering systemic circulation. Age is also a factor: hepatic enzyme efficiency changes over time, which is one reason body odour can shift after 40.

Gut microbiome composition

The balance of bacterial species in the gut determines how much skatole is produced from a given amount of tryptophan. Several genera catalyse the decarboxylation of indole-3-acetic acid to skatole, including Clostridium, Bacteroides, Eubacterium, and others.^[1][2] Certain Lactobacillus species, particularly L. reuteri and L. acidophilus, metabolise tryptophan through different pathways, producing indole-3-aldehyde and indole-3-lactic acid.^[1] When these species are abundant, they can compete for the same tryptophan substrate, diverting it away from the skatole-producing pathway. The relationship is not absolute: some Lactobacillus species have also been reported as skatole producers in animal models,^[1] and the net effect depends on which species are present.

In dysbiotic mice, the intestinal contents have been found to be deficient in AhR agonists, and administration of Lactobacillus species, which naturally produce these compounds, has improved outcomes.^[5] Dietary fibre plays a role here as well: increased fibre availability redirects microbial tryptophan metabolism toward indole-3-propionic acid and other non-malodorous metabolites.^[9]

In plain terms Why does this happen to some people and not others?

Three things work together: how much protein you eat (more protein means more raw material for skatole), which bacteria live in your gut (some produce skatole, others compete against them), and how well your liver processes it (some people's livers are genetically slower at clearing skatole). Two people eating the same diet can have very different skatole levels because of differences in their gut bacteria and liver enzymes.

5. Conditions linked to faecal body odour

Several medical conditions can increase skatole and indole production or impair their clearance, resulting in faecal body odour. Understanding these conditions helps distinguish between a dietary or microbial imbalance that can be managed and an underlying condition that requires medical attention.

Gut dysbiosis and small intestinal bacterial overgrowth (SIBO)

Gut dysbiosis, a shift in the microbial community toward a proteolytic, putrefactive profile, is associated with elevated levels of skatole and indole. Faecal skatole concentrations in individuals with digestive disorders have been measured at 80 to 100 micrograms per gram, compared with approximately 5 micrograms per gram in healthy adults.^[2] In small intestinal bacterial overgrowth (SIBO), bacteria that normally reside in the colon colonise the small intestine, producing odorous metabolites higher in the digestive tract. The clinical association between SIBO and systemic symptoms is well established, though the specific contribution of SIBO to faecal body odour via elevated skatole has not been isolated in published studies.

Inflammatory bowel disease

Crohn's disease and ulcerative colitis alter tryptophan metabolism. Serum tryptophan levels are significantly reduced in patients with active IBD, and the kynurenine pathway is markedly activated, with elevated levels of downstream metabolites such as quinolinic acid correlating with disease activity.^[10] This diversion of tryptophan toward the inflammatory kynurenine pathway reduces the amount available for microbial metabolism in the gut, altering the overall balance of tryptophan catabolites. The dysbiotic microbiome associated with active IBD may further shift the microbial community toward proteolytic species, though the specific effect on faecal skatole concentrations in IBD patients has not been quantified in published studies.

Liver dysfunction

Because the liver is the primary site of skatole clearance, any condition that impairs hepatic function can increase circulating skatole levels. This includes chronic liver disease, cirrhosis, and acute hepatic injury. Skatole is metabolised in the liver through several cytochrome P450 enzymes, including CYP1A, CYP2E1, and CYP2A isoforms, some of which are induced by skatole itself through the aryl hydrocarbon receptor.^[4] Conditions that compromise hepatic enzyme capacity may reduce the efficiency of this clearance pathway.

The TMAU differential: fishy versus faecal

Trimethylaminuria (TMAU) is sometimes considered when a person reports persistent body odour, but TMAU produces a characteristically fishy odour from trimethylamine (TMA), caused by mutations in the FMO3 gene that impair the conversion of TMA to its odourless oxide form.^[11] A faecal body odour suggests skatole and indole from tryptophan metabolism, whereas a fishy body odour suggests TMA from choline and carnitine metabolism. For a full explanation of the ammonia and TMA pathway, our article on why your sweat smells like ammonia (publishing shortly) covers both routes in detail. The distinction matters because the dietary management, the diagnostic tests, and the underlying biochemistry are different for each condition.

Post-antibiotic disruption

Broad-spectrum antibiotics reduce overall gut microbial diversity and alter the community's metabolic output.^[12] This disruption can shift the balance between saccharolytic and proteolytic species, though the specific effect on skatole production has not been quantified in clinical studies. Recovery of microbial diversity can take weeks to months after antibiotic cessation.

In plain terms Could my faecal body odour be caused by a medical condition?

Several conditions can cause or worsen faecal body odour. A gut bacterial imbalance (dysbiosis or SIBO) can increase skatole production. Inflammatory bowel disease diverts tryptophan away from normal gut metabolism, altering the balance of metabolites your body produces. Liver problems can reduce your body's ability to clear skatole from your blood. And antibiotics reduce gut microbial diversity, which can disrupt the balance between bacteria that produce skatole and those that suppress it. If the odour appeared suddenly, especially after illness, medication, or dietary change, a medical evaluation can identify whether an underlying condition is involved.

6. What can be done

Because faecal body odour from the skatole pathway involves production in the gut, transport through the blood, and expression at the skin surface, effective management requires addressing more than one point in the chain.

Dietary modification

Reducing the volume of unabsorbed tryptophan reaching the colon can lower skatole production. This does not mean eliminating protein. It means balancing protein intake with adequate fibre to promote saccharolytic over proteolytic fermentation. Preclinical research suggests that increasing dietary fibre intake, particularly prebiotic fibres such as inulin-type fructans, can redirect microbial tryptophan metabolism away from skatole production.^[9][8] This has been demonstrated in animal models and in vitro human faecal cultures, though not yet in controlled human clinical trials. A healthcare professional or registered dietitian can guide dietary adjustments based on the current evidence without compromising nutritional adequacy.

Microbial rebalancing

In animal models, shifting the gut microbiome toward saccharolytic fermentation has reduced the metabolites associated with proteolytic bacteria. Lactobacillus species can divert tryptophan through the indole-3-aldehyde pathway, producing aryl hydrocarbon receptor (AhR) ligands rather than skatole. The intestinal contents of dysbiotic mice have been found to be deficient in AhR agonists, and Lactobacillus species are among the bacteria that naturally produce these compounds.^[5] Whether supplementing with these species translates to reduced skatole production and reduced body odour in humans has not been demonstrated in clinical trials. A healthcare professional or gastroenterologist can guide probiotic and prebiotic strategies based on the current evidence.

Topical management: why conventional deodorants fall short

Conventional deodorants and antiperspirants were designed to address body odour produced by bacteria on the skin surface breaking down sweat. They are effective against the volatile fatty acid and thioalcohol pathways (the sour and onion-like odours) because those pathways operate entirely on the skin. For a complete breakdown of how and why deodorants fail across all odour pathways, read why your deodorant stops working. Faecal body odour from the skatole pathway operates through a different mechanism: the molecule arrives at the skin through the bloodstream, not through bacterial conversion of sweat precursors.

This means antimicrobial deodorants, which work by reducing the population of odour-producing skin bacteria, have limited effect on skatole-derived odour. The odour source is internal, and the skin bacteria are not producing it.

Products marketed as whole-body deodorants do not change this limitation. They are the same antimicrobial chemistry repositioned as a spot treatment for more areas of the body. Applying an antimicrobial product to the chest, back, and groin instead of just the armpits increases the coverage area, but the mechanism remains the same: it targets bacteria. If the odour is not being produced by bacteria on the skin surface, covering more skin with an antibacterial product does not address the source. The skatole pathway requires a fundamentally different mechanism, one that captures the molecule itself rather than targeting the bacteria that are not producing it.

Molecular trapping offers that approach. Certain compounds have cage-like molecular structures with internal cavities that can physically enclose small aromatic compounds, forming stable inclusion complexes that prevent the odorant from volatilising into the air. Selecting the right trapping compound for a given odorant depends on structural compatibility: the cavity must match the size and geometry of the target molecule. The VCS uses molecular trapping compounds selected specifically for their compatibility with skatole and indole. This is a fundamentally different mechanism from antimicrobial deodorants: instead of targeting bacteria, which are not producing the skatole in this pathway, the product captures the molecule itself at the skin surface.

There is another critical distinction. Because skatole reaches the skin through the bloodstream, it surfaces across the entire body, not only in the armpits. An underarm deodorant, even one with effective molecular trapping, covers a fraction of the skin area involved. Whole-body topical coverage is what this pathway demands. The BVI Lamellar Barrier Primer is a full-body daily lotion formulated with molecular trapping compounds that address skatole and indole across the entire skin surface. For people with skatole-pathway body odour, this is the relevant product, used in combination with the Bio-Clear: Poly Acid Daily Wash and, where needed, the Bio-Volatile Inhibitor Endurance Concentrate for additional protection in targeted zones. For a full explanation of what each product does and how they work together, read the Volatile Control System introduction.

In plain terms Why does regular deodorant not help with this kind of body odour?

Regular deodorants fight bacteria on your skin that produce sour or onion-like smells from sweat. Faecal body odour is different because the smelly molecule, skatole, arrives at your skin from inside your body through your bloodstream. Killing skin bacteria does not stop it. A topical product designed for this problem needs to physically trap the skatole molecule as it reaches the skin surface, preventing it from reaching the air. The VCS uses molecular trapping compounds that do exactly this. And because skatole reaches your skin everywhere through your bloodstream, not just your armpits, this requires a whole-body product. The BVI Lamellar Barrier Primer is a full-body daily lotion designed for exactly this purpose.

When to see a doctor

Persistent faecal body odour warrants medical evaluation, particularly if it appeared suddenly, worsened after illness, antibiotic use, or hormonal transition (read perimenopause and body odour if that applies), or is accompanied by digestive symptoms such as bloating, abdominal pain, diarrhoea, or changes in stool consistency. These patterns may suggest gut dysbiosis, SIBO, inflammatory bowel disease, malabsorption, or impaired liver function.

A gastroenterologist can investigate with stool analysis (including microbial profiling), breath tests for SIBO, blood tests for liver and kidney function, and, where clinically indicated, imaging of the gastrointestinal tract. The objective is to identify whether an underlying condition is driving elevated skatole production or impairing its clearance.

A doctor addresses the underlying condition. The Volatile Control System addresses whatever component of the odour is manageable at the skin surface. If the VCS cannot fully resolve the odour, no other topical product will. What remains belongs to medicine.

---